Cash · 2011–2025
Arrowhead Pharmaceuticals cash
$202M+274.2% · FY2025
Arrowhead Pharmaceuticals (ARWR) reported $202M in cash for fiscal 2025, +274.2% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $202M | +274.2% | Open → |
| FY20242024-12-31 | $53.9M | −7.4% | Open → |
| FY20232023-12-31 | $58.2M | −71.2% | Open → |
| FY20222022-12-31 | $202M | +120.8% | Open → |
| FY20212021-12-31 | $91.6M | −34.5% | Open → |
| FY20202020-12-31 | $140M | −69.7% | Open → |
| FY20192019-12-31 | $461M | +142.9% | Open → |
| FY20182018-12-31 | $190M | +1,545.7% | Open → |
| FY20172017-12-31 | $11.5M | −88.7% | Open → |
| FY20162016-12-31 | $102M | +64.2% | Open → |
| FY20152015-12-31 | $62.2M | −40.2% | Open → |
| FY20142014-12-31 | $104M | +74.2% | Open → |
| FY20132013-12-31 | $59.7M | +1,937.3% | Open → |
| FY20122012-12-31 | $2.9M | −56.7% | Open → |
| FY20112011-12-31 | $6.8M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +27.4%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Arrowhead Pharmaceuticals cash |url=https://companiesranked.com/en/company/arrowhead-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Arrowhead Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/arrowhead-pharmaceuticals/cash-on-handBibTeX
@misc{companiesranked-en-company-arrowhead-pharmaceuticals-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Arrowhead Pharmaceuticals cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/arrowhead-pharmaceuticals/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000879407-26-000034 · February 5, 2026
{{cite web |title=Arrowhead Pharmaceuticals cash — 10-Q (0000879407-26-000034) |url=https://www.sec.gov/Archives/edgar/data/879407/000087940726000034/arwr-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.